Vitamin D and Breast Cancer

被引:47
作者
Bertone-Johnson, Elizabeth R. [1 ]
机构
[1] Univ Massachusetts, Div Biostat & Epidemiol, Dept Publ Hlth, Amherst, MA 01003 USA
关键词
Breast Neoplasms; Vitamin D; Review; 25-Hydroxyvitamin D; 1,25-dihydroxyvitamin D; Diet; Case-control Studies; Cohort Studies; RECEPTOR GENE POLYMORPHISMS; 25-HYDROXYVITAMIN D-1-ALPHA-HYDROXYLASE; ADOLESCENT DIET; COLON-CANCER; D DEFICIENCY; RISK; SUNLIGHT; ASSOCIATION; EXPOSURE; MORTALITY;
D O I
10.1016/j.annepidem.2009.01.003
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Though the relationship between vitamin D and breast cancer remains unclear, a growing body of evidence suggests that vitamin D may modestly reduce risk. A large number of in vitro studies indicate that vitamin D can inhibit cell proliferation and promote apoptosis and cell differentiation in breast tumor tissue. Results from analytic studies of sunlight exposure and dietary intake have been inconsistent but together generally support a modestly protective role of vitamin D, at least in some population subgroups. Studies using blood vitamin D metabolites to assess vitamin D status may be less prone to misclassification than those of diet and sunlight exposure. Overall, the two prospective and four case-control studies of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D tend to support a protective effect in older women. The relationship between common vitamin D receptor polymorphisms and risk remains unclear. Many questions about this relationship clearly remain, including the utility of assessing vitamin D through diet and sunlight exposure, the relationship between plasma metabolites, and the potential modifying effects of age, menopausal status and tumor characteristics. Given that vitamin D status is modifiable, additional prospective studies are necessary to determine if vitamin D may have important potential for breast cancer prevention. Ann Epidemiol 2009; 19:462-467. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:462 / 467
页数:6
相关论文
共 52 条
[1]   Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer [J].
Bertone-Johnson, ER ;
Chen, WY ;
Holick, MF ;
Hollis, BW ;
Colditz, GA ;
Willett, WC ;
Hankinson, SE .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (08) :1991-1997
[2]   Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population [J].
Bretherton-Watt, D ;
Given-Wilson, R ;
Mansi, JL ;
Thomas, V ;
Carter, N ;
Colston, KW .
BRITISH JOURNAL OF CANCER, 2001, 85 (02) :171-175
[3]   Vitamin D receptor gene polymorphisms in breast cancer [J].
Buyru, N ;
Tezol, A ;
Yosunkaya-Fenerci, E ;
Dalay, N .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2003, 35 (06) :550-555
[4]   Prostatic 25-hydroxyvitamin D-1α-hydroxylase and its implication in prostate cancer [J].
Chen, TC ;
Wang, LL ;
Whitlatch, LW ;
Flanagan, JN ;
Holick, MF .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 88 (02) :315-322
[5]   Associations between Polymorphisms in the vitamin D receptor and breast cancer risk [J].
Chen, WY ;
Bertone-Johnson, ER ;
Hunter, DJ ;
Willett, WC ;
Hankinson, SE .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (10) :2335-2339
[6]   Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer [J].
Colston, KW ;
Hansen, CM .
ENDOCRINE-RELATED CANCER, 2002, 9 (01) :45-59
[7]  
Curran JE, 1999, INT J CANCER, V83, P723, DOI 10.1002/(SICI)1097-0215(19991210)83:6<723::AID-IJC4>3.0.CO
[8]  
2-3
[9]   25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of lα-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer [J].
de Lyra, Eduardo Carneiro ;
da Silva, Iran Amorim ;
Hirata Katayama, Maria Lucia ;
Brentani, Maria Mitzi ;
Nonogaki, Sueli ;
Sampaio Goes, Joao Carlos ;
Azevedo Koike Folgueira, Maria Aparecida .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2006, 100 (4-5) :184-192
[10]   No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer [J].
Dunning, AM ;
McBride, S ;
Gregory, J ;
Durocher, F ;
Foster, NA ;
Healey, CS ;
Smith, N ;
Pharoah, PDP ;
Luben, RN ;
Easton, DF ;
Ponder, BAJ .
CARCINOGENESIS, 1999, 20 (11) :2131-2135